Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-04 @ 10:11 AM
Study NCT ID:
NCT00333359
Status:
COMPLETED
Last Update Posted:
2013-07-22
First Post:
2006-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
Sponsor:
XenoPort, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-01
First Submit QC Date:
None
Study First Post Date:
2006-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-04-28
Results First Submit QC Date:
None
Results First Post Date:
2011-06-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-02-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-07-15
Last Update Post Date:
2013-07-22
Last Update Post Date Type:
ESTIMATED